Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
bill cassidy
boston blog main
boston top stories
deals
johnson & johnson
life sciences
mark warner
medicaid
meiragtx
2
×
national blog main
national top stories
new york blog main
new york top stories
novartis
spinal muscular atrophy
abiraterone
ac immune
achromatopsia
acorda therapeutics
aduro biotech
agenus
aldeyra therapeutics
aleksandra rizo
alexion pharmaceuticals
alzheimer's disease
apalutamide
atypical hemolytic uremic syndrome
beta-thalassemia
biogen
biotech
bluebird bio
boulder/denver blog main
boulder/denver top stories
caelum biosciences
cancer
cancer immunotherapy
celgene
chuck grassley
clinical trials
corvus pharmaceuticals
What
gene
2
×
age
alzheimer’s
bigger
biggest
bio
come
companies
deal
different
drug
emerging
fail
gave
increases
j
johnson
latest
meiragtx
morning
past
pharmaceutical
plan
prescription
price
prices
raise
roundup
signal
signals
start
therapies
therapy
typically
year
years
Language
Current search:
meiragtx
×
gene
×
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
